AI assistant
PTC THERAPEUTICS, INC. — Director's Dealing 2018
Jan 5, 2018
31046_dirs_2018-01-05_b78c3637-1a0e-42ca-8117-5207b84e38b2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2018-01-03
Reporting Person: Souza Marcio (Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-01-03 | Common Stock | A | 1079 | — | Acquired | 1742 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-01-03 | Stock Option (Right To Buy) | $18.01 | A | 75000 | Acquired | 2028-01-02 | Common Stock (75000.0) | Direct |
| 2018-01-03 | Stock Option (Right To Buy) | $18.01 | A | 2696 | Acquired | 2028-01-02 | Common Stock (2696.0) | Indirect |
Footnotes
F1: Restricted stock unit (RSU) award vests in four equal annual installments over four years, commencing on January 3, 2019. Upon vesting, each RSU will convert into one share of the issuer.
F2: Includes 663 shares acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2017.
F3: This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019.